Caricamento...

Targeted Therapies for Hepatocellular Carcinoma

Unlike most solid tumors, incidence and mortality of hepatocellular carcinoma (HCC) have increased in the US and Europe in the last decade. Most patients are diagnosed at advanced stages, so there is an urgent need for new systemic therapies. Sorafenib, a tyrosine kinase inhibitor (TKI), has demonst...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Villanueva, Augusto, Llovet, Josep M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682501/
https://ncbi.nlm.nih.gov/pubmed/21406195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2011.03.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !